Risk factor
Very high price volatility
Profitability factor
Undervalued vs peers
About
Medicskin Holdings Limited operates as an investment holding entity, specializing in the provision of medical skin care services across Hong Kong. Operating under the Medicskin brand, its centers deliver a wide array of dermatological solutions. These services tackle various skin ailments, including acne, pigmentation issues, rosacea, dermatitis, eczema, and warts. The company also focuses on aesthetic improvements, offering treatments for skin rejuvenation, facial sculpting, and body contouring. Specific procedures address concerns like acne scars, enlarged pores, the removal of unwanted moles, and permanent hair reduction. Medicskin employs advanced technologies such as dermal fillers, intense focused ultrasound, radio frequency, and a variety of laser and light-based therapies for facial contouring and other treatments. Beyond specialized procedures, it markets skincare products and provides general health management services. A significant part of its offering includes preventative health screenings, encompassing genetic tests, thorough physical examinations, laboratory analyses, diagnostic imaging, and comprehensive body check-ups. Moreover, the company extends its expertise to men's facial, skin, and body care, and administers vaccines for shingles and human papillomavirus. Founded in 2000, Medicskin Holdings Limited is based in Central, Hong Kong, and operates as a subsidiary of Topline Worldwide Limited.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is of fair value on EV/EBITDA, undervalued on P/FC.